Notre mission a toujours été de trouver la bonne personne. Avec la même orientation, #SpecializedDiagnostics, Werfen et Omixon forment la combinaison parfaite. Ensemble, nous contribuerons à #PoweringPatientCare.

Learn More

Nous contacter: +1-800-552-2025 ou info@werfen.com

Visit Werfen.com

Catégories d'articles

Filtres et recherche

Transfusion

Past – Present – Future Smoothing the Blood Supply

Diagnosis & Management of FNAIT-Fetal and Neonatal Alloimmune Thrombocytopenia

Webinaire d'Immucor sur le soutien à la transfusion sanguine pendant la transplantation

Challenges, Myths and Facts in Pediatric Transfusion

ImmuLINK Panel ID

Trombocitopenia fetal/neonatal aloinmune: ¿qué?, ¿cuándo?,¿cómo? y ¿por qué?

Seguimiento y tratamiento de gestantes sensibilizadas

Inmunohematología de los grupos sanguíneos en el embarazo

Anti-e: autoantibody or alloantibody; concerning or benign?

A look at Latin America's journey in voluntary blood donation.

Identifying antibodies, beyond a panel.

The ABO group as a population marker in Latin America.

Interference of Monoclonal Antibody Treatments in Immunohematologic Studies.

Importance of Natural Antibody Titration in Universal Donors.

Knowing the Blood Groups Present in the Population We Serve Impacts the Safety of Our Patients.

Application of Special Reagents in Complex Cases.

RhD variants - Influence of molecular alterations on serological tests.

Impact of RhCE variants on routine immunohematology

Strategy for the National Registry of donors of rare phenotype and of interest in transfusion medicine.

Platelet alloimmunization and representative cases.

Serology and Molecular to Resolve an ABO Discrepancy.

The use of Anti-CD47 (MAB) has opened a new era in the therapy of cancer and other diseases.

Generalities in Immunohematology

Clinical Importance of Molecular Research in Immunohematology

Molecular techniques used to determine blood group alleles.

Antibodies of undetermined specificity

Solid Phase Platelet Crossmatch.

Isohemagglutinin test: validation and management of platelet concentrate transfusions

Platelet Crossmatch

RhD variants: The importance of serological detection to direct molecular research

RhCE variants: how to detect, characterize and define clinical significance

Platelet Refractoriness

Detection of Irregular Antibodies Using Type and Screen in a Hospital Emergency Center

Molecular Immunohematology-Relevant Problems

ABO Antibody Titration in Donors: A Challenge for Blood Banks

Autoimmune Hemolytic Anemia: Case Report

Management of Patients Refractory to Platelet Transfusion

Hemolytic disease of the newborn due to maternal alloimmunization

Autoimmune Hemolytic Anemia: An unusual case

Molecular typing of blood group genes as a diagnostic aid

Impact of the BeadChip on the identification of RH variants

Isohemagglutinin test: validation and management of platelet concentrate transfusions

Réactifs spéciaux en immunohématologie

Subgrupos Sanguíneos: Mito o Realidad

Los Donantes de Reactivos Son la Clave de la Fabricación

Más allá de la prueba de antiglobulina humana positiva

Experiencia en la Implementación de un Método de Genotipificación Aplicado a Inmunohematología

BBTS – Werfen Webinar: The Dark Art of Abstracts and Posters

Effective and timely management of Platelet Refractoriness

BBTS – Werfen Webinar: CAR-T Cell Therapy

5 Isnor Drive, Dartmouth. NS, Canada B3B 1M1

Appel +1-800-552-2025 x6115

E-mail info@werfen.com